Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular ... next-generation products, Aranesp and ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

If these products expires and if biosimilars enter to the market during this time that can threaten AMGN’s profitability. Plus in the obesity treatment market where Amgen developed MariTide ...

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease ... market both new and existing products domestically and ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we ...

As Stelara biosimilars chip away at sales in Europe and off-brand rivals start to grace the stage in the U.S., Johnson & ...

Women's Health Market size is expected to reach US$ 66 Billion by 2033, from US$ 41.3 Billion in 2023, growing at a CAGR of 4.8%. Lawrence John Prudour +91 91308 55334 ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...